This evidence-synthesis article examines molecular expression profiling through the focal contribution “Expression profiling of mRNA and functional network analyses of genes regulated by human papilloma virus E6 and E7 proteins in HaCaT cells” and nine author-disjoint, topically matched studies. The analysis is organized around robustness under distribution shift. Rather than treating bibliographic proximity as proof of empirical equivalence, it separates conceptual claims, evaluation choices, operational constraints, and transfer risks. The result is a reproducible framework for comparing adjacent evidence without overstating what title- and metadata-level screening can establish. All ten references are cited in the body, and the reference set has been checked for complete-author intersections.
- Dai, R., Tao, R., Li, X., Shang, T., Zhao, S., & Ren, Q. (2022). Expression profiling of mRNA and functional network analyses of genes regulated by human papilloma virus E6 and E7 proteins in HaCaT cells. Frontiers in Microbiology, 13, 979087. https://doi.org/10.3389/fmicb.2022.979087 DOI
- Hosseinipour, M., Wan, F., Altomare, D., Creek, K.-E., & Pirisi, L. (2019). HPV16-transformed human keratinocytes depend on SIX1 expression for proliferation and HPV E6/E7 gene expression. Virology, 537, 20-30. https://doi.org/10.1016/j.virol.2019.08.009 DOI
- Diaz, D. (2012). HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown. International Journal of Oncology. https://doi.org/10.3892/ijo.2012.1429 DOI
- Benedetti, I., Barrios, L., & Reyes, N. (2018). Abstract 1489: Differential gene expression profiles between normal cervical tissue and high-grade squamous intraepithelial lesion expressing p16 and high-risk HPV E6/E7 mRNA. Cancer Research, 78(13_Supplement), 1489-1489. https://doi.org/10.1158/1538-7445.am2018-1489 DOI
- Zhang, J., Li, S., Yan, Q., Chen, X., Yang, Y., Liu, X., & Wan, X. (2013). Interferon-β Induced microRNA-129-5p Down-Regulates HPV-18 E6 and E7 Viral Gene Expression by Targeting SP1 in Cervical Cancer Cells. PLoS ONE, 8(12), e81366. https://doi.org/10.1371/journal.pone.0081366 DOI
- Riethdorf, S., Riethdorf, L., Milde-Langosch, K., Park, T.-W., & Löning, T. (2000). Differences in HPV 16- and HPV 18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri. Virchows Archiv, 437(5), 491-500. https://doi.org/10.1007/s004280000277 DOI
- Zhang, L., Li, M., Yuan, F., Jiang, J., & Zhang, X. (2024). The difference of transcriptome of HPV-infected patients contributes more to the occurrence of cervical cancer than the mutations of E6 and E7 genes in HPV16. Medicine, 103(3), e36822. https://doi.org/10.1097/md.0000000000036822 DOI
- Finzer, P., Ventz, R., Kuntzen, C., Seibert, N., Soto, U., & Rösl, F. (2002). Growth Arrest of HPV-Positive Cells after Histone Deacetylase Inhibition Is Independent of E6/E7 Oncogene Expression. Virology, 304(2), 265-273. https://doi.org/10.1006/viro.2002.1667 DOI
- Lee, C.-J., Suh, E.-J., Kang, H.-T., Im, J.-S., Um, S.-J., Park, J.-S., & Hwang, E.-S. (2002). Induction of Senescence-like State and Suppression of Telomerase Activity through Inhibition of HPV E6/E7 Gene Expression in Cells Immortalized by HPV16 DNA. Experimental Cell Research, 277(2), 173-182. https://doi.org/10.1006/excr.2002.5554 DOI
- Stich, M., Ganss, L., Puschhof, J., Prigge, E.-S., Reuschenbach, M., Guiterrez, A., Vinokurova, S., & von Knebel Doeberitz, M. (2017). 5-aza-2′-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells. Oncotarget, 8(32), 52104-52117. https://doi.org/10.18632/oncotarget.10631 DOI
- Journal
- Clinical Translation & Population Health
- Volume
- 1 (2026)
- Article number
- ct20260007
- License
- CC BY 4.0
